510(k) device
LIAISON Anti-HAV
DiaSorin, Inc. · Hepatitis A Test (Antibody And Igm Antibody) (LOL, Class II) · First FDA decision Dec 5, 2008, newest Dec 9, 2022Liver disease and liver cancer
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
510(k) pathway
Device trials
0
Naming "LIAISON Anti-HAV"
MAUDE reports
0
Brand "LIAISON Anti-HAV", since 2015
PubMed studies
0
Mentioning "LIAISON Anti-HAV"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing LIAISON Anti-HAV
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
K223403 · Decided Dec 9, 2022 · 30 days after receipt
Device type: Hepatitis A Test (Antibody And Igm Antibody) (LOL) · Laboratory Medicine & Pathology
3 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Hepatitis Panel/Acute Hepatitis PanelNational determinationOn the books190.33Updated Oct 1, 2026
- Screening for Hepatitis C Virus (HCV) in AdultsNational analysisUnder reviewCAG-00436RUpdated Sep 23, 2026
- Screening for Hepatitis C Virus (HCV) in AdultsNational analysisReview closedCAG-00436NUpdated Sep 22, 2026
- Screening for Hepatitis B Virus (HBV) InfectionNational analysisReview closedCAG-00447NUpdated Sep 22, 2026
- Hepatitis Panel/Acute Hepatitis Panel (Addition of ICD-9-CM 790.5, Other nonspecific abnormal serum enzyme levels, as a covered indication)Coding analysisReview closedCAG-00335NUpdated Sep 14, 2026
- Hepatitis Panel/Acute Hepatitis Panel (Addition of ICD-9-CM 790.4, Elevation of Levels of Transaminase or Lactic Acid Dehydrogenase)Coding analysisReview closedCAG-00304NUpdated Sep 14, 2026
- Hepatitis Panel (Removal of ICD-9-CM Code 784.69, Other symbolic dysfunction, from the list of Codes Covered by Medicare)Coding analysisReview closedCAG-00283NUpdated Sep 14, 2026
- Screening for Hepatitis C Virus (HCV) in AdultsNational determinationOn the books210.13Updated Apr 7, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "LIAISON Anti-HAV", any status and sponsor, newest update first.
No registered device study names "LIAISON Anti-HAV".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "LIAISON Anti-HAV", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LOL
428 reports: 426 malfunction, 1 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "LIAISON Anti-HAV"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code LOL.
- Eti-Ha-Igmk Plus KitDiaSorin, Inc. · PMA 2005
- Advia Centaur Hav Total Assay, Advia Centaur Hav Total Quality Control MaterialsBayer Healthcare, Diagnostics Division · PMA 2005
- Advia Centaur Hav IGM Ready Pack ReagentsBayer Healthcare, LLC · PMA 2004
- Abbott Axsym Havab 2.0Abbott Laboratories · PMA 2004
- Abbott Axsym Havab-M 2.0Abbott Laboratories · PMA 2004
- Ab-Havk Ria Assay/Eti-Ab-Havk PlusDiasorin · PMA 2001
- Ha-Igmk Ria Assay/Eti-Ha-Igmk PlusDiaSorin, Inc. · PMA 2001
- ADVIA Centaur HAV IgM AssaySiemens Healthcare Diagnostics, Inc. · 510(k) 2016
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.